StonvexLoading…
StonvexStonvexStonvexCore line items from EVER's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $190.85M | $692.52M | $497.20M | $323.26M |
Operating Income | $23.42M | $58.34M | $39.70M | $22.16M |
Net Income | $18.67M | $99.31M | $41.56M | $14.70M |
EPS (Diluted) | $0.51 | $2.63 | $1.10 | $0.60 |
Total Assets | $323.97M | $326.91M | $256.05M | $241.42M |
Total Liabilities | $83.11M | $88.87M | $81.12M | $71.15M |
Cash & Equivalents | $178.49M | $171.38M | $145.77M | $148.19M |
Free Cash Flow OCF − CapEx | $28.06M | $90.32M | $64.47M | $46.01M |
Shares Outstanding | 36.94M | 37.75M | 37.80M | 37.84K |